Skip to content

Erector Spina Plane Block for Multilevel Major Spinal Surgery

Effect of Ultrasound-guided Bilateral Erector Spina Plan Block for Postoperative Analgesia in Patients Undergoing Multilevel Posterior Spinal Instrumentation.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05983393
Enrollment
42
Registered
2023-08-09
Start date
2021-09-01
Completion date
2023-08-07
Last updated
2023-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Post Operative Pain

Keywords

Pain, postoperative analgesia, Erector spinae plane block, posterior spinal instrumentation

Brief summary

Erector spinae plane (ESP) block is an interfacial plane block with visceral and somatic analgesic activity at paraspinal muscles. This study aims to examine the postoperative analgesic efficacy of ESP block in patients undergoing posterior spinal instrumentation

Detailed description

Postoperative patient-controlled analgesia in the ESP group and control group will be compared with 24-hour morphine consumption and NRS scores at different time points. In addition, the need for rescue analgesics and patient satisfaction will be evaluated.

Interventions

PROCEDUREErector spinae plane block

Erector spinae plane block was performed

PROCEDUREControl

Erector spinae plane block was not applied.

Sponsors

Kahramanmaras Sutcu Imam University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* ASA I-III patients * Agreed to participate in the study

Exclusion criteria

* Patients with infection at the injection site * Coagulopathy Allergy to amide-type local anesthetics * History of peripheral neuropathy * Hepatic and/or renal failure * Refusing the procedure * Patients with heart disease * Patients who have previously undergone surgery from the same area

Design outcomes

Primary

MeasureTime frameDescription
opioid consumptionup to 24 hourThe amount of morphine consumed in milligrams in the first 24 hours was determined with a patient-controlled analgesia pump.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026